Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEDICO (South Egypt Drug Industries Company) is a leading Egyptian pharmaceutical manufacturer established in 1990 and headquartered in 6th of October City. The company is recognized for its advanced manufacturing capabilities, particularly in the production of biotechnology-derived products such as human insulin and recombinant proteins. SEDICO's extensive portfolio covers a wide array of therapeutic areas, including endocrinology, cardiology, and infectious diseases, offering both branded generics and specialized hospital products. As a major player in the Middle East and Africa, the company operates state-of-the-art facilities that adhere to international GMP standards and provides contract manufacturing services to various global partners. SEDICO is a key subsidiary of the Arab Company for Drug Industries and Medical Appliances (ACDIMA), playing a vital role in regional drug security.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sedico.